BNP PARIBAS FINANCIAL MARKETS - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 90 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2020. The put-call ratio across all filers is 0.13 and the average weighting 0.5%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$20,367,000
-98.5%
172
-98.5%
0.00%
-100.0%
Q4 2020$1,397,478,000
+153132.2%
11,832
+118220.0%
0.00%
Q1 2019$912,000
+20.2%
100.0%0.00%
Q4 2018$759,000
-5.1%
100.0%0.00%
Q3 2018$800,000
-100.0%
10
-100.0%
0.00%
-100.0%
Q2 2018$6,358,113,000
+4.6%
64,010
-14.7%
0.01%0.0%
Q1 2018$6,075,810,000
+770941.9%
75,010
+750000.0%
0.01%
Q4 2017$788,000
-14.6%
100.0%0.00%
Q3 2017$923,000100.00%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q4 2020
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 137,557$11,142,0006.62%
COMGEST GLOBAL INVESTORS S.A.S. 637,752$51,658,0001.13%
Black Creek Investment Management Inc. 411,525$33,334,0001.09%
Hillhouse Capital Management 618,391$50,090,0000.88%
RUDMAN ERROL M 21,301$1,725,0000.83%
JUPITER ASSET MANAGEMENT LTD 263,705$21,360,0000.65%
York Capital Management Global Advisors, LLC 341,616$27,671,0000.62%
VONTOBEL ASSET MANAGEMENT INC 873,968$71,525,0000.51%
Temasek Holdings (Private) Ltd 990,000$80,190,0000.44%
WASATCH ADVISORS LP 292,216$23,669,0000.31%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders